"Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"
Recruitment status was Recruiting
The purpose of the study is to identify the barriers for effective treatment of depression, specifically whether modified CHIS Scale is a valid tool for identifying the high risk patients for depression.
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||"Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"|
- proportion of anti-depressant prescriptions filled [ Time Frame: August 1, 2008 through July 31, 2009 ] [ Designated as safety issue: No ]
|Study Start Date:||August 2009|
|Estimated Study Completion Date:||October 2009|
|Estimated Primary Completion Date:||September 2009 (Final data collection date for primary outcome measure)|
Patients diagnosed with depression before April 15, 2009
Depression is a major illness that affects 10% of the population in a medical setting. It is often under diagnosed and under treated. It is an illness that can challenge a persons ability to perform even routine daily activities. Review of the charts of patients diagnosed with depression showed 80% of the patients do not have follow up appointments. We wondered if modified CHIS scale could identify the risk factors for medication non-adherence.
We hypothesised that modified CHIS Scale an effective tool ,for identifying the compliance of patients with the antidepressant medication.
We are conducting a retrospective cohort study at two of our residency based clinics by interviewing approximately 100 patients with CHIS Scale and PHQ9 Questionnaire on their office visits
Please refer to this study by its ClinicalTrials.gov identifier: NCT00984685
|United States, Pennsylvania|
|Scranton Temple Residency Program||Recruiting|
|Scranton, Pennsylvania, United States, 18510|
|Contact: John R Guzek, MD 570-357-7731 firstname.lastname@example.org|
|Principal Investigator: John R Guzek, MD|
|Sub-Investigator: Srividhya R Lakshmanan, MD|
|Principal Investigator:||John R Guzek, MD||Scranton-Temple Residency Program|